“Necrotic enteritis and dysbiosis are the two major challenges facing poultry production since the 2006 ban on antibiotic growth promoters in the European Union,” stated Professor Richard Ducatelle of Ghent University. He made the remarks during his presentation at the BIOMIN seminar on “The Multifacets of Gut Performance and Lameness,” which was held at the Faculty of Veterinary Medicine, Ghent University in Belgium on Nov. 10.

Necrotic enteritis, widespread in broilers, costs the industry $2 billion worldwide annually. Dysbiosis, or dysbacteriosis—characterized by an imbalance between beneficial and harmful gut bacteria—and leaky gut constitute a multi-factorial disease with real consequences for poultry health and performance, according to Gunther Antonissen of Ghent University. “Inflammation, diarrhea, wet litter, digestibility issues, welfare problems, disease, and performance problems are all associated with the loss of intestinal epithelial integrity,” he explained. Fortunately, attention to feed formulation, management practices and feed additives can influence gut performance. Prof. Ducatelle outlined how both prebiotics and probiotics (direct fed microbials) can protect intestinal health.

“Poultry-to-poultry beneficial bacterial strains will persist longer in a bird’s gastrointestinal tract,” explained Dr. Wael Abdelrahman, Technical Consultant at BIOMIN. “Different probiotic strains will colonize different parts of the gastrointestinal tract and, if used together, will have an overall greater effect compared to a single strain probiotic,” he continued. Combining a prebiotic and probiotic can provide further benefits.

Tackling BCO lameness

Prof. Robert Wideman of the University of Arkansas provided insights into a lameness caused by stress and bacterial infection in broilers, including research findings on Bacterial Chondronecrosis with Osteomyelitis (BCO). “BCO is a common cause of lameness in the US and EU that typically affects 1.5% of broilers grown past 40 days of age. ‘Epidemic’ outbreaks can affect more than 15% of a flock in some cases,” he noted. Peer-reviewed study results show that PoultryStar® can reduce the incidence of BCO lameness by more than half, even across different genetic lines.

Providing further evidence, Gino Totté, Director at Panagro Health and Nutrition, shared results from a farm in the Netherlands. Citing genuine performance and net return on investment gains in 75% of barns applying PoultryStar® for broilers, he highlighted “a clear reduction in BCO lameness accompanied by less antibiotic use.”


The harm of Campylobacter

Campylobacter is not a harmless commensal,” declared Prof. Tom Humphrey of Swansea University. “It represents an international problem and has a direct impact on broiler performance, health and welfare.” The threat to human health is real: the World Health Organization named Campylobacter the number one food borne pathogen and long-term side effects can occur in about 1% of cases. Left unchecked, Campylobacter “will become a trade issue and a political issue as companies and regulators examine levels in poultry production more closely.” He emphasized the need for further research to better understand and control Campylobacter.

“A competitive exclusion strategy using synbiotic (combination prebiotic and probiotic) supplemented feed can play a role in reducing Campylobacter prevalence in birds,” remarked Luca Vandi, BIOMIN Technical & Marketing Director for EMA. He shared results of a scientific study showing a statistically significant reduction in Campylobacter levels in broilers using PoultryStar®.

With its long experience in scientifically formulated feed additives for livestock, BIOMIN has become a leading authority on gut performance and probiotics.

The conference, held in partnership with key local BIOMIN partner, Panagro Health and Nutrition, brought together more than 100 attendees from across the poultry industry representing 13 countries. It ended with a tour of the Ghent University Faculty of Veterinary Medicine’s facilities.